Bristol Myers Squibb
Tracked across 15 events · 146 articles · First seen Sep 26, 2025 · Last active Jun 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
New research presented at the 2026 American Society of Clinical Oncology>>> Annual Meeting indicates that GLP-1 medications, widely used for weight loss and diabetes, may significantly reduce the risk of developing various cancers, including breast…
Impact: Bristol Myers Squibb>>>'s immunotherapies Opdivo and Yervoy are mentioned as potentially faring better when patients are also taking GLP-1 drugs, suggesting a possible interaction with the immune system.
Jun 02, 2026 · 37 articles
Tech
Impact: Bristol Myers Squibb is jointly developing pumitamig with BioNTech, which is being used in the clinical trial collaboration with Boehringer Ingelheim.
Apr 09, 2026 · 6 articles
Regulatory
Impact: Bristol Myers Squibb is one of the major drugmakers that has reached pricing agreements with the Donald Trump administration to avoid the new tariffs.
Apr 02, 2026 · 23 articles
Business
Kinaxis is hosting its annual Kinexions North America conference from June 1-3 in Las Vegas, bringing together global supply chain, business, and technology leaders. The conference will focus on advancements in agentic AI and orchestration…
Impact: Bristol Myers Squibb is participating in the Kinaxis conference as a speaker, sharing insights on navigating disruption and improving operational outcomes in supply chain management.
May 28, 2026 · 6 articles
Business
Optellum, a leader in AI-enabled lung cancer diagnostics, announced a significant milestone, surpassing 250 clinical sites and analyzing over 3 million cases to date. This achievement highlights the accelerating impact of Optellum's technology in empowering…
Impact: Bristol Myers Squibb is a partner of Optellum in the US, supporting the commercial momentum of Optellum's AI solutions in lung cancer care.
Jun 04, 2026 · 6 articles
Domestic
Impact: Bristol Myers Squibb, among other pharmaceutical companies, had previously announced investments in U.S. production due to the threat of tariffs, but the new, higher tariffs introduce further uncertainty.
Sep 26, 2025 · 7 articles
Business
Nxera Pharma Co., Ltd. announced on June 10, 2026, that it has joined OpenFold, a non-profit AI research consortium dedicated to developing open-source AI software tools for biology and drug discovery. This move aligns with…
Impact: Bristol Myers Squibb is a pharmaceutical company that participates in the OpenFold consortium, benefiting from access to AI-enabled tools for drug discovery.
Jun 10, 2026 · 9 articles
Regulatory
Impact: Bristol Myers Squibb has a presence in Hyderabad with R&D and capability centers, contributing to India — Telangana's life sciences ecosystem.
Jan 21, 2026 · 6 articles
Business
Impact: Dieter Weinand has led business operations for companies including Bristol Myers Squibb.
Apr 07, 2026 · 9 articles
Business
Ovid Therapeutics Inc. announced the appointment of Anna Greka>>>, a distinguished physician-scientist and biotech entrepreneur, to its Board of Directors, effective June 15, 2026. Anna Greka>>> brings over 25 years of experience in advancing biological…
Impact: Bristol Myers Squibb acquired the lead asset from Goldfinch Bio, a company founded by Anna Greka>>>.
Jun 03, 2026 · 6 articles
60
Optellum partnered Bristol Myers SquibbOptellum surpasses 250...
40
Bristol Myers Squibb share insightsKinaxis Hosts Kinexions...
NEWSDESK
Track Bristol Myers Squibb live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard